Boris Hadaschik

Essen University Hospital — Germany

Medicine · Health Sciences

67h-index23.9kcitations785works3.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Prostate Cancer Treatment and Research(363), Prostate Cancer Diagnosis and Treatment(296), Radiopharmaceutical Chemistry and Applications(146), Bladder and Urothelial Cancer Treatments(123), Cancer, Lipids, and Metabolism(65)

Publications784 total

Patient‐reported outcomes: active surveillance vs radical therapies in low‐risk prostate cancer
British Journal of Urology·2026Open Access
Zweitlinien Prostatakrebstherapie nach Versagen eines Androgenrezeptor-Signalweg-Inhibitors
Onkologische Welt·2026
The Pelvic Rosetta Classification Project: An Interdisciplinary Proposal for a Lymph Node Map of the Pelvis in Prostate Cancer
Universität Zürich, ZORA·2026Open Access
Artificial intelligence assisted 3D in the robotic urooncology? A systematic review and narrative synthesis of current applications, challenges and future directions
Canadian Journal of Urology·2026
Correction: Comparative proteome and serum analysis identified FSCN1 as a marker of abiraterone resistance in castration-resistant prostate cancer
Prostate Cancer and Prostatic Diseases·2025Open Access
New targets of PET imaging for renal cancer
Seminars in Nuclear Medicine·2025Open Access
Potential value of [68Ga]Ga-FAPI-46 PET in patients with metastatic urothelial carcinoma: a bi-centric analysis
European Journal of Nuclear Medicine and Molecular Imaging·2025Open Access
Evaluation of the TARGET score for MRI-based detection of prostate cancer recurrence in patients treated with HIFU hemiablation
European Journal of Radiology·2025Open Access
The German Cancer Consortium (DKTK) multi-center prospective phase 1/2 68Ga-PSMA-11 PET-imaging trial in newly-diagnosed high-risk prostate cancer: Safety and diagnostic accuracy compared to histopathology and their impact on patient management
European Journal of Nuclear Medicine and Molecular Imaging·2025Open Access
The German Cancer Consortium (DKTK) multi-center prospective phase 1/2 Ga-PSMA-11 PET-imaging trial in newly-diagnosed high-risk prostate cancer: Safety and diagnostic accuracy compared to histopathology and their impact on patient management
Universität Zürich, ZORA·2025Open Access
The Pelvic Rosetta Classification Project: An Interdisciplinary Proposal for a Lymph Node Map of the Pelvis in Prostate Cancer
Journal of Nuclear Medicine·2025
Value of Additional Systematic Cores During Magnetic Resonance Imaging–guided Targeted Biopsy in Prostate Cancer Screening for Young Men: Results from the PROBASE Trial
European Urology Oncology·2025Open Access
Clinical Impact of Changes in Tumor Uptake and Volume on PSMA PET/CT During [ <sup>177</sup> Lu]Lu-PSMA Therapy in Metastatic Castration-Resistant Prostate Cancer
Journal of Nuclear Medicine·2025
Leveraging Sarcopenia index by automated CT body composition analysis for pan cancer prognostic stratification
npj Digital Medicine·2025· 1 citedOpen Access
Folgetherapie beim metastasierten kastrations-resistenten Prostatakarzinom (mCRPC) nach Versagen einer Therapie mit NHA und Taxanen
Onkologische Welt·2025
A network meta-analysis of the safety of systemic treatments in patients with metastatic hormone-sensitive prostate cancer
Frontiers in Oncology·2025Open Access
Tumor likelihood estimation on MRI prostate data by utilizing k-Space information
Proceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition·2025· 1 cited
Biparametric vs Multiparametric MRI for Prostate Cancer Diagnosis
JAMA·2025· 22 citedOpen Access
MK-5684 als Folgetherapie beim mCRPC
Uro-News·2025
3106P Perioperative chemo-immunotherapy with Durvalumab for operable muscle-invasive urothelial carcinoma (MIUC): Final analysis of the single arm phase II trial SAKK 06/17
Annals of Oncology·2025
page 1 of 40Next →

Frequent Co-authors

Uwe Haberkorn(14), Markus Hohenfellner(12), Jan Philipp Radtke(11), Ali Afshar‐Oromieh(10), Klaus Kopka(10), Ken Herrmann(10), Matthias Roethke(10), Frederik L. Giesel(9), Matthias Eder(8), David Bonekamp(8), Heinz-Peter Schlemmer(8), Claudia Kesch(7), Tim Holland‐Letz(6), Clemens Kratochwil(6), Matthias Eiber(6), Wolfgang P. Fendler(6), Martin T. Freitag(6), Wilfried Roth(6), Timur H. Kuru(6), Matthew R. Smith(5)